Trial Profile
Safety of rabeprazole in patients under multiple treatments.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2012
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastrointestinal disorders
- Focus Adverse reactions
- Sponsors Janssen-Cilag
- 15 Nov 2009 Status changed from active, no longer recruiting to discontinued.
- 14 Aug 2007 New trial record.